Clinical stage EGFR inhibitors irreversibly alkylate Bmx kinaseHUR, Wooyoung; VELENTZA, Anastasia; ZAGORSKA, Anna et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 22, pp 5916-5919, issn 0960-894X, 4 p.Article

The Polycomb Group Protein Bmi-1 Is Essential for the Growth of Multiple Myeloma CellsJAGANI, Zainab; WIEDERSCHAIN, Dmitri; WARMUTH, Markus et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 13, pp 5528-5538, issn 0008-5472, 11 p.Article

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityBARRETINA, Jordi; CAPONIGRO, Giordano; REDDY, Anupama et al.Nature (London). 2012, Vol 483, Num 7391, pp 603-607, issn 0028-0836, 5 p.Article

Genomic sequencing of colorectal adenocarcinomas identifies a recurrent YTI1A-TCF7L2 fusionBASS, Adam J; LAWRENCE, Michael S; RUI JING et al.Nature genetics. 2011, Vol 43, Num 10, pp 964-968, issn 1061-4036, 5 p.Article

The effects of Bcr-Abl on C/EBP transcription-factor regulation and neutrophilic differentiation are reversed by the Abl kinase inhibitor imatinib mesylateSCHUSTER, Christine; FORSTER, Karin; DIERKS, Henning et al.Blood. 2003, Vol 101, Num 2, pp 655-663, issn 0006-4971, 9 p.Article

Protein Kinase C Inhibitor Sotrastaurin Selectively Inhibits the Growth of CD79 Mutant Diffuse Large B-Cell LymphomasNAYLOR, Tara L; HUAPING TANG; YAO, Yung-Mae et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 7, pp 2643-2653, issn 0008-5472, 11 p.Article

Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemiaYIGUO HU; YUHUA LIU; PELLETIER, Shawn et al.Nature genetics. 2004, Vol 36, Num 5, pp 453-461, issn 1061-4036, 9 p.Article

Src family kinases: Potential targets for the treatment of human cancer and leukemiaWARMUTH, Markus; DAMOISEAUX, Robert; YI LIU et al.Current pharmaceutical design. 2003, Vol 9, Num 25, pp 2043-2059, issn 1381-6128, 17 p.Article

Trisomy 12 and elevated GLI1 and PTCH1 transcript levels are biomarkers for Hedgehog-inhibitor responsiveness in CLLDECKER, Sarah; ZIRLIK, Katja; DIERKS, Christine et al.Blood. 2012, Vol 119, Num 4, pp 997-1007, issn 0006-4971, 11 p.Article

Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitorsJIANMING ZHANG; ADRIAN, Francisco J; GUO, Gui-Rong et al.Nature (London). 2010, Vol 463, Num 7280, pp 501-506, issn 0028-0836, 6 p.Article

The ITK-SYK Fusion Oncogene Induces a T-Cell Lymphoproliferative Disease in Mice Mimicking Human DiseaseDIERKS, Christine; ADRIAN, Francisco; GUO, Gui-Rong et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 15, pp 6193-6204, issn 0008-5472, 12 p.Article

Dual-specific Src and Abl kinase inhibitors, PP1 and CGP76030, inhibit growth and survival of cells expressing imatinib mesylate-resistant Bcr-Abl kinasesWARMUTH, Markus; SIMON, Nicola; MITINA, Olga et al.Blood. 2003, Vol 101, Num 2, pp 664-672, issn 0006-4971, 9 p.Article